1. Adelaide Research & Scholarship

Search


Current filters:






Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 18 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2021Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerSinghal, D.; Hahn, C.N.; Feurstein, S.; Wee, L.Y.A.; Moma, L.; Kutyna, M.M.; Chhetri, R.; Eshraghi, L.; Schreiber, A.W.; Feng, J.; Wang, P.P.-S.; Babic, M.; Parker, W.T.; Gao, S.; Moore, S.; Das, S.; Thomas, D.; Pattnaik, S.; Brown, A.L.; D'Andrea, R.J.; et al.
2020Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionPagani, I.S.; Dang, P.; Saunders, V.A.; Grose, R.; Shanmuganathan, N.; Kok, C.H.; Carne, L.; Rwodzi, Z.; Watts, S.; McLean, J.; Braley, J.; Altamura, H.; Yeung, D.T.; Branford, S.; Yong, A.S.M.; White, D.L.; Hughes, T.P.; Ross, D.M.
2018Identification of microRNA biomarkers of response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma using next generation sequencingChiam, K.; Mayne, G.; Watson, D.; Woodman, R.; Bright, T.; Michael, M.; Karapetis, C.; Irvine, T.; Phillips, W.; Hummel, R.; Wang, T.; Pimlott, L.; Marri, S.; Astill, D.; Ruszkiewicz, A.; Thompson, S.; Hussey, D.
2015Phase 2 study of intralesional PV-10 in refractory metastatic melanomaThompson, J.; Agarwala, S.; Smithers, B.; Ross, M.; Scoggins, C.; Coventry, B.; Neuhaus, S.; Minor, D.; Singer, J.; Wachter, E.
2008Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotypeEnglish, D.; Young, J.; Simpson, J.; Jenkins, M.; Southey, M.; Walsh, M.; Buchanan, D.; Barker, M.; Haydon, A.; Royce, S.; Roberts, A.; Parry, S.; Hopper, J.; Jass, J.; Giles, G.
2009Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancerSmit, E.; Burgers, S.; Biesma, B.; Smit, H.; Eppinga, P.; Dingemans, A.; Joerger, M.; Schellens, J.; Vincent, A.; van Zandwijk, N.; Groen, H.
2021AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerOar, A.; Lee, M.; Le, H.; Wilson, K.; Aiken, C.; Chantrill, L.; Simes, J.; Nguyen, N.; Barbour, A.; Samra, J.; Sjoquist, K.M.; Moore, A.; Espinoza, D.; Gebski, V.; Yip, S.; Chu, J.; Kneebone, A.; Goldstein, D.
2013TLR 2 and 4 responsiveness from isolated peripheral blood mononuclear cells from rats and humans as potential chronic pain biomarkersKwok, Y.; Tuke, S.; Nicotra, L.; Grace, P.; Rolan, P.; Hutchinson, M.; Price, T.J.
2013Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitisSelinger, C.; Andrews, J.; Dent, O.; Norton, I.; Jones, B.; McDonald, C.; Cowlishaw, J.; Barr, G.; Selby, W.; Leong, R.
2013Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapyPadman, S.; Padbury, R.; Beeke, C.; Karapetis, C.; Bishnoi, S.; Townsend, A.; Maddern, G.; Price, T.

Discover